Search alternatives:
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
63121
Intrahepatic IFN or ISG expression in mice infected with the two HCV strains.
Published 2016“…Data in <b>A</b> are mean ± the standard error of the mean (SEM); n = 3 to 5. …”
-
63122
-
63123
-
63124
-
63125
-
63126
-
63127
Naturally emitted FS-1 and MS-1 pulses overlapped by continuous pure tones.
Published 2015“…<p><b>The relation between interference pulse duration and the difference between MS-1 and pure tone frequencies at different frequency and velocity levels</b>. a,b, c: naturally emitted FS-1 and MS-1 signals overlapped by (a) 100 Hz/0.69 mm/s, (b) 125 Hz/1.13 mm/s and (c) 150 Hz/0.60 mm/s pure tones. d: mean interference pulse duration (SD<40% of the mean value, N = 3–23, n = 6) of naturally emitted MS-1 signals overlapped by 100 Hz/0.22 mm/s (black diamonds), 125 Hz/0.22 mm/s (open squares) or 150 Hz/0.22 mm/s (grey triangles) pure tone vibration. …”
-
63128
Experimental validation of the predicted temporal dynamics.
Published 2010“…The cell population treated with 0.3% serum exhibited a bimodal distribution of GFP at the 24th h . In contrast, a monomodal distribution was observed at 24th h in the cell population treated with 5% serum. …”
-
63129
Table_1_Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy.docx
Published 2023“…Eight OAAs (9.68%) have reported a decrease in LVEF, and four of these drugs, namely, encorafenib, lorlatinib, ripretinib, and sunitinib, have specific management recommendations. …”
-
63130
Table2_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx...
Published 2023“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
-
63131
Table1_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx...
Published 2023“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
-
63132
Table3_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx...
Published 2023“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
-
63133
Table4_Fire, volcanism and climate change: the main factors controlling mercury (Hg) accumulation rates in Tropical Lake Lantoa, Sulawesi, Indonesia (∼16,500–540 cal yr BP).xlsx...
Published 2023“…The Holocene Transition was marked by a decrease in HgAR (µ = 8, 3.50–18.84 μg m<sup>−2</sup> yr<sup>−1</sup>) as humid conditions precluded forest burning, followed by high HgAR (µ = 11.35, 3.30–158.32 μg m<sup>−2</sup> yr<sup>−1</sup>) in the Early Holocene. …”
-
63134
Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
63135
DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
63136
Table_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
63137
Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
63138
DataSheet_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
63139
Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”
-
63140
Table_3_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Canc...
Published 2021“…Most of tumors (88%) were triple negative. No significant decreases in LVEF were observed. The mean baseline LVEF was 66.6% (52-86) and after a median follow-up of 5 years, mean LVEF was 66 (54.5-73). …”